NCT07350473Not yet recruiting
Effects of Vibration-Assisted Physical Activity in Type-2 Diabetes
Vibration-Assisted Physical Activity for Glycaemic Control in Type-2 Diabetes: A Randomised Controlled Trial in the Kingdom of Saudi Arabia
Source: ClinicalTrials.gov · Last updated 23 Feb 2026
Brief summary (registry, in English)
The World Health Organization ranks Saudi Arabia as having the 7th highest rate of type-2 diabetes in the world. This therefore makes diabetes the most challenging health problem facing Saudi Arabia. Importantly, physical activity has been shown to improve disease symptoms and overall health in patients with type-2 diabetes. However, findings relating to the prevalence of physical inactivity in the Saudi population confirm that a sedentary lifestyle is on the rise, within physical inactivity levels in adults being 80.5%. Therefore, interventions aimed at reducing physical inactivity using bespoke modalities pertinent to Saudi Arabia are clearly warranted. There have been no fully powered, placebo-controlled trials of localised wearable calf vibration in T2DM within the Kingdom of Saudi Arabia. The proposed study will address this gap by evaluating a 12 week, home based, seated calf vibration intervention in Saudi adults with T2DM, recruited from the Jazan Diabetes and Endocrinology Center. A three-arm design will compare active localised vibration, a sham vibration condition and usual care.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 305 (estimated)
- First submitted
- 9 Jan 2026
- Start date
- 1 Dec 2026
- Primary completion date
- 1 Jun 2029
- Lead sponsor
- University of Central Lancashire
- Diseases
- Type 2 diabetes
- NCT number
- NCT07350473
What you commit to
- Study type: Interventional
- Planned participants: 305
- From 1 Dec 2026 to the primary completion date, 1 Jun 2029
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Cognitive impairment precluding consent or participation
- Additional medical conditions that prevent safe physical activity (e.g. severe arthritis or advanced heart failure)
- Enrolment in any other clinical trial designed to influence type-2 diabetes symptoms.
Other
- Pregnancy
Who the study is looking for
- Clinically established diagnosis of type-2 diabetes for at least 12 months
- Previously sedentary
- Knowledgeable about hypoglycaemia
- Aged over 18 years
- Capacity to give informed consent.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.